QGEN Latest Press Releases

-- August 28, 2026 --

10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences PRNewswire 2:39 PM

-- August 27, 2026 --

QIAGEN Launches QIAsymphony Connect for Automated Clinical Nucleic Acid Extraction Business Wire 4:05 PM

-- August 24, 2026 --

QIAGEN Appoints Jonathan M. Pratt as Chief Executive Officer Business Wire 9:47 AM

-- August 10, 2026 --

QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel Business Wire 4:05 PM

-- August 5, 2026 --

QIAGEN Exceeds Q2 2026 Outlook as Pillars Deliver Solid Sales Growth; Reaffirms Full-Year Outlook Business Wire 4:05 PM

-- July 15, 2026 --

QIAGEN Highlights Molecular Testing Solutions Supporting Response to Growing U.S. Cyclospora Outbreak Business Wire 4:05 PM

QIAGEN N.V. to Release Results for Q2 2026 and Hold Webcast Business Wire 8:48 AM

-- July 14, 2026 --

QIAGEN Expands QIAstat-Dx Bloodstream Infection Testing Menu in Europe Business Wire 4:05 PM

-- June 15, 2026 --

QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and Biopharma Business Wire 1:30 AM

-- June 4, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN PRNewswire 10:09 AM

-- June 2, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN Globe Newswire 5:41 PM

-- May 28, 2026 --

QIAGEN Supports Infectious Disease Research and Surveillance Efforts for Bundibugyo Ebolavirus Outbreak Business Wire 4:05 PM

-- May 26, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN Globe Newswire 5:35 PM

-- May 21, 2026 --

QGEN INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Qiagen N.V. Globe Newswire 8:00 PM

-- May 20, 2026 --

QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows Business Wire 4:05 PM

Qiagen (QGEN) Securities Fraud Investigation - Levi & Korsinsky PRNewswire 9:00 AM

-- May 19, 2026 --

QGEN INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Qiagen N.V. Business Wire 7:00 PM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN Globe Newswire 5:11 PM

QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA Business Wire 4:05 PM

-- May 15, 2026 --

QIAGEN INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Qiagen N.V. on Behalf of Qiagen Stockholders and Encourages Investors to Contact the Firm Globe Newswire 10:47 AM

-- May 14, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN PRNewswire 10:20 PM

QGEN SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations Globe Newswire 7:00 PM

Levi & Korsinsky Announces Investigation of Securities Claims Against Qiagen N.V. (QGEN) Globe Newswire 9:00 AM

-- May 13, 2026 --

QGEN Investor Alert: Levi & Korsinsky Investigates Qiagen (QGEN) for Potential Securities Fraud PRNewswire 9:00 AM

-- May 12, 2026 --

QIAGEN N.V. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud Business Wire 8:00 PM

QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting Business Wire 2:00 AM

-- May 7, 2026 --

QGEN SHAREHOLDER INVESTIGATION: Levi & Korsinsky Investigates Qiagen for Possible Securities Law Violations Globe Newswire 9:00 AM

QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing Business Wire 6:00 AM

-- May 6, 2026 --

QGEN Investors Have Opportunity to Join Qiagen N.V. Fraud Investigation with the Schall Law Firm Globe Newswire 6:31 PM

QIAGEN Reports Full Results for Q1 2026 Business Wire 4:05 PM

-- April 28, 2026 --

Qiagen N.V. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses Globe Newswire 8:30 PM

-- April 27, 2026 --

QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook Business Wire 4:16 PM

-- April 16, 2026 --

QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026 Business Wire 4:05 PM

-- April 14, 2026 --

QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel Business Wire 4:05 PM